Fig. 3

Distribution of half-lives at different concentrations of 2,3,4,7,8-PeCDF compared with previously reported half-lives. White bars indicate the numbers of patients with different half-lives reported by us in 2009 [11]. Black bars indicate the numbers of patients with different half-lives as calculated in this study. (a) is the distribution of patients who have concentraion of 2,3,4,7,8PeCDF more than 500 pg/g lipid. (b) is the distirubtion for more than 200 pg/g lipid and less thane 500 pg/g lipid. (c) is the distiribution for more than 100 pg/g lipid and less than 200 pg/g lipid. (d) is the distribution for more than 50 pg/g lipid and less than 100 pg/g lipid. (e) is then distribution for more than 20 pg/g lipid and less than 50 pg/g lipid